European farm exports decline overall as pork shipments drop while beef sales surge
EU agri-food exports decreased 1% year-on-year to EUR 138.7 billion in the first seven months of 2026, with pork shipments falling EUR 930 million due to lower prices and reduced demand from major Asian markets. Beef and veal exports grew EUR 295 million driven by increased sales to Turkey, while dairy imports declined following the previous year's elevated pricing. The trade surplus widened to EUR 30.1 billion, supported by declining cocoa prices and reduced cereal imports.
The EU's agri-food sector experienced mixed performance through mid-2026, with significant divergence across livestock categories. Pork producers faced particular headwinds from both structural and disease-related pressures, including the African swine fever outbreak that struck Spanish operations in late 2025 and subsequent demand erosion in key Asian markets. Meanwhile, beef and veal producers capitalized on stronger demand, particularly from Turkish buyers, indicating shifting international preferences for different protein sources.
Import dynamics revealed notable adjustments in EU purchasing patterns. Dairy imports contracted substantially from 2025's elevated levels, suggesting price normalization in global markets. Cereal imports fell markedly, with wheat and rice purchases declining in both volume and value, reflecting reduced import demand from traditional suppliers like Canada where maize and grain shipments contracted accordingly.
These trade shifts could affect EU farming communities differently by sector and geography, with pork producers potentially facing income pressure while beef operations benefit from market conditions. Consumers in importing nations like Turkey and Japan may experience varying protein availability and pricing. The widening trade surplus, supported partly by commodity price movements, suggests the EU maintains competitive agricultural standing, though this masks underlying vulnerabilities in specific export categories dependent on disease-free status and Asian market access.